Author

Sandeep Sharma

Institutions: Lundbeck (Denmark), Lundbeck (United States)

Observed institutions: Lundbeck (Denmark), Lundbeck (United States)

OpenAlex ID: A5137006054

Real-world Effectiveness of Eptinezumab in Patients in Whom ≥1 Prior Anti-CGRP Preventive Treatment had Failed: 6-month Results for an Ongoing Prospective Study (P10-15.006)

2026 · Emad Estemalik, Stephane Regnier, et al. · Neurology

Patient-reported outcomes from a real-world evidence study in individuals with migraine initiating eptinezumab after ≥1 prior calcitonin gene-related peptide (CGRP)-targeted preventive therapy

2026 · Amaal J. Starling, Stephane A. Regnier, et al. · Cephalalgia Reports

Works count: 2

Citation count:

H-index:

I10-index: